Latest パチスロ ブルー スリー
- December 11, 2015
- NHI Drug Price Listing of PENTASA Granules 94%, a treatment for Ulcerative Colitis and Crohn's Disease
- November 5, 2015
- パチスロ ブルー スリー Pharmaceutical and PeptiDream Reach Agreement for Peptide Discovery Collaboration
- November 5, 2015
- Consolidated Financial パチスロ ブルー スリー (For the second Quarter Ended Sep 30,2015)- Supplementary Information
- November 5, 2015
- Summary of Consolidated Financial パチスロ ブルー スリー (For the second Quarter Ended Sep 30,2015)[Japanese Standard]
- October 15, 2015
- MSD Submits New Drug Application for Antiallergic Agent, Desloratadine to be Co-marketed with パチスロ ブルー スリー
- August 31, 2015
- パチスロ ブルー スリー Pharmaceutical and Synmosa Biopharma Corporation Sign License Agreement of Imidafenacin in Taiwan
- August 17, 2015
- Approval received for PENTASA Granules 94%, a treatment for Ulcerative Colitis and Crohn's Disease
- August 17, 2015
- Approval received for KIPRES OD Tablets 10mg, a treatment for bronchial asthma and allergic rhinitis
- July 30, 2015
- Summary of Consolidated Financial パチスロ ブルー スリー (For the First Quarter Ended June 30,2015)[Japanese Standard]
- July 30, 2015
- Consolidated Financial パチスロ ブルー スリー (For the First Quarter Ended June 30,2015)- Supplementary Information
- May 20, 2015
- パチスロ ブルー スリー of Eklira Genuair, a treatment for COPD
- May 13, 2015
- Summary of Consolidated Financial パチスロ ブルー スリー (For the fiscal year ended March 31, 2015) [Japanese Standard]
- March 26, 2015
- Genuair, a dry powder inhaler for COPD treatment, selected for iF UNIVERSAL DESIGN award for 2015
- March 26, 2015
- Approval received for Eklira Genuair, a treatment for COPD
- February 12, 2015
- Signing of パチスロ ブルー スリー-marketing Agreement for multi-purpose disinfectant cleaner RUBYSTA
- February 2, 2015
- Summary of Consolidated Financial パチスロ ブルー スリー (For the Third Quarter Ended Dec 31,2014)[Japanese Standard]
- February 2, 2015
- Consolidated Financial パチスロ ブルー スリー (For the Third Quarter Ended Dec 31,2014)- Supplementary Information
- December 1, 2014
- パチスロ ブルー スリー of Flutiform® 50 Aerosol - 120 inhalations, Flutiform® 125 Aerosol - 120 inhalations , a combination drug for asthma treatment
- November 27, 2014
- Signing of パチスロ ブルー スリー-Marketing Agreement on Investigational Antiallergic Agent, Desloratadine for Japan
- November 4, 2014
- Summary of consolidated financial パチスロ ブルー スリー (November 4, 2014)
- November 4, 2014
- Consolidated Financial パチスロ ブルー スリー (For the Second Quarter Ended september 30,2014)- Supplementary Information
- September 10, 2014
- EISAI AND パチスロ ブルー スリー ENTER INTO AGREEMENT CONCERNING COMPOUND LIBRARY USE FOR THE DEVELOPMENT OF NEW ANTIBACTERIAL AGENTS
- July 29, 2014
- Summary of Consolidated Financial パチスロ ブルー スリー (For the First Quarter Ended June 30, 2014) [Japanese Standard]
- July 22, 2014
- パチスロ ブルー スリー signed a License Agreement with Merck on Vibegron for Overactive Bladder in Japan
- February 4, 2014
- Third Quarter Consolidated Financial パチスロ ブルー スリー for the Ending Fiscal Year March 31, 2014
- February 4, 2014
- Summary of Consolidated Financial パチスロ ブルー スリー(For the Third Quarter Ended December 31, 2013) [Japanese Standard]
- November 19, 2013
- パチスロ ブルー スリー of Flutiform, a combination drug for asthma treatment
- November 5, 2013
- Summary of Consolidated Financial パチスロ ブルー スリー (For the Second Quarter Ended September 30, 2013) [Japanese Standard]
- October 17, 2013
- パチスロ ブルー スリー and Kissei announce the initiation of a Phase I clinical trial of KRP-EPA605/ KEA-0447 for the treatment of overactive bladder
- September 20, 2013
- Approval received for Flutiform, a combination drug for asthma treatment
- July 30, 2013
- Consolidated Financial パチスロ ブルー スリー (For the First Quarter Ended June 30,2013)- Supplementary Information
- July 30, 2013
- Summary of Consolidated Financial パチスロ ブルー スリー (For the First Quarter Ended June 30,2013)[Japanese Standard]
- May 9, 2013
- Summary of Consolidated Financial パチスロ ブルー スリー(For the fiscal year ended March 31, 2013)
- May 9, 2013
- Financial パチスロ ブルー スリー for the Fiscal 2012, the Year Ended March 31, 2013- Supplementary Information
- February 4, 2013
- Consolidated Financial パチスロ ブルー スリー (For the Third Quarter Ended December 31,2012)- Supplementary Information
- February 4, 2013
- Summary of Consolidated Financial パチスロ ブルー スリー (For the Third Quarter Ended December 31,2012)[Japanese Standard]
- November 7, 2012
- Consolidated Financial パチスロ ブルー スリー (For the Second Quarter Ended september 30,2012)- Supplementary Information
- November 7, 2012
- Summary of Consolidated Financial パチスロ ブルー スリー (For the Second Quarter Ended september 30,2012)[Japanese Standard]
- October 9, 2012
- Announcement regarding transfer of "Pekiron Cream 0.5%" topical antifungal medication business.
- September 25, 2012
- Application filed for KRP-108, an Anti-asthmatic Treatment, in Japan
- July 31, 2012
- Summary of Consolidated Financial パチスロ ブルー スリー(For the First Quarter Ended June 30, 2012)
- July 31, 2012
- First Quarter Consolidated Financial パチスロ ブルー スリー for the Fiscal Year Ending March 31, 2013
- May 28, 2012
- Establishment of a Subsidiary
